Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 54enzalutamide 47apalutamide 37Specimen Handling 37Androgen Antagonists 34Abiraterone Acetate 32Prednisone 29darolutamide 28Radiosurgery 27Pluvicto 23Docetaxel 23abiraterone 22Radiotherapy 21Leuprolide 19Biopsy 17relugolix 14acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 14Surveys and Questionnaires 13gallium 68 PSMA-11 12Triptorelin Pamoate 12Gonadotropin-Releasing Hormone 12Radiation 11Nivolumab 112-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 11cabazitaxel 10bicalutamide 10X-Rays 10Standard of Care 10Goserelin 9Carboplatin 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Nutritional Support × 90 days × Clear all
NCT01802346 2026-06-05

Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer

University of Southern California

Phase NA Active not recruiting
130 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡